Redmile Group’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-715,607
| Closed | -$385K | – | 58 |
|
|
2024
Q4 | $385K | Hold |
715,607
| – | – | 0.03% | 60 |
|
|
2024
Q3 | $680K | Hold |
715,607
| – | – | 0.04% | 62 |
|
|
2024
Q2 | $698K | Hold |
715,607
| – | – | 0.04% | 61 |
|
|
2024
Q1 | $1.13M | Hold |
715,607
| – | – | 0.04% | 74 |
|
|
2023
Q4 | $567K | Hold |
715,607
| – | – | 0.02% | 68 |
|
|
2023
Q3 | $558K | Hold |
715,607
| – | – | 0.03% | 66 |
|
|
2023
Q2 | $662K | Buy |
+715,607
| New | +$662K | 0.03% | 71 |
|